Satol, Basit S.
HRN: 09-91-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2022
11/27/2022
IV
900 Mg
OD
Cathether Associated UTI
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes